Dup15q 2014
Recent articles
Treatments for Angelman syndrome face critical window
Drugs designed to treat Angelman syndrome may alleviate symptoms only if given during a ‘critical period’ early in development. That’s the upshot from unpublished results presented yesterday at a conference in Boston.
Treatments for Angelman syndrome face critical window
Drugs designed to treat Angelman syndrome may alleviate symptoms only if given during a ‘critical period’ early in development. That’s the upshot from unpublished results presented yesterday at a conference in Boston.
Explore more from The Transmitter
‘Bioethics and Brains: A Disciplined and Principled Neuroethics,’ an excerpt
In their new book, published earlier this week, Giordano and Shook examine how ethics can guide neuroscience research and its real-world applications.
‘Bioethics and Brains: A Disciplined and Principled Neuroethics,’ an excerpt
In their new book, published earlier this week, Giordano and Shook examine how ethics can guide neuroscience research and its real-world applications.
AI tool estimates social ability by analyzing speech
The system’s code and training data—drawn from one of the largest databases of speech recordings from autistic people—are openly available.
AI tool estimates social ability by analyzing speech
The system’s code and training data—drawn from one of the largest databases of speech recordings from autistic people—are openly available.
About-faces in U.S. federal science funding put neuroscientists on edge
“It’s hard to know what’s real,” says neuroscientist Josh Dubnau after a dizzying week in which diversity-related grant applications were pulled from study sections only to be reinstated five days later, among other reversals.
About-faces in U.S. federal science funding put neuroscientists on edge
“It’s hard to know what’s real,” says neuroscientist Josh Dubnau after a dizzying week in which diversity-related grant applications were pulled from study sections only to be reinstated five days later, among other reversals.